E. Galmozzi
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 21
- Hepatitis C virus research 21
- Epidemiology 19
- Hepatitis B Virus Studies 13
- Liver Disease Diagnosis and Treatment 10
- Co-authors
- Luca Valenti (12 shared papers)Silvia Fargion (7 shared papers)Paola Dongiovanni (7 shared papers)Anna Ludovica Fracanzani (6 shared papers)F. Facchetti (17 shared papers)Valério Nobili (3 shared papers)Raffaela Rametta (5 shared papers)Sylvie Ménard (3 shared papers)
- Journals
- Journal of Hepatology (8 papers)Digestive and Liver Disease (6 papers)Hepatology (5 papers)Journal of Viral Hepatitis (3 papers)Journal of Cellular Physiology (2 papers)
- Partner nations
- ItalyUnited StatesAustralia
In The Last Decade
E. Galmozzi
44 papers receiving 2.5k citations
E. Galmozzi's Hit Papers
Peers
Comparison fields: 5 of 88
- Hepatology 583
- Epidemiology 1.3k
- Endocrinology, Diabetes and Metabolism 381
- Oncology 531
- Cell Biology 284
Countries citing papers authored by E. Galmozzi
This map shows the geographic impact of E. Galmozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Galmozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Galmozzi more than expected).
Fields of papers citing papers by E. Galmozzi
This network shows the impact of papers produced by E. Galmozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Galmozzi. The network helps show where E. Galmozzi may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Galmozzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease† Hit paper breakdown → | 2010 | 509 |
| 2 | 2007 | 467 | |
| 3 | 2009 | 236 | |
| 4 | 2010 | 227 | |
| 5 | 2004 | 202 | |
| 6 | 2010 | 198 | |
| 7 | 2016 | 123 | |
| 8 | 2011 | 68 | |
| 9 | 2010 | 52 | |
| 10 | 2020 | 49 | |
| 11 | 2014 | 36 | |
| 12 | 2018 | 36 | |
| 13 | 2006 | 36 | |
| 14 | 2004 | 29 | |
| 15 | 2004 | 28 | |
| 16 | 2013 | 28 | |
| 17 | 2010 | 28 | |
| 18 | 2002 | 26 | |
| 19 | 2010 | 25 | |
| 20 | The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma. | 2003 | 22 |
About E. Galmozzi
E. Galmozzi is a scholar working on Hepatology, Epidemiology, Molecular Biology, Infectious Diseases and Oncology, having authored 45 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (13 papers), Liver Disease Diagnosis and Treatment (10 papers), RNA Research and Splicing (4 papers), RNA modifications and cancer (4 papers), HIV/AIDS drug development and treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Folate and B Vitamins Research (2 papers). The work is most often cited by research in Hepatology (583 citations), Epidemiology (1.3k citations), Endocrinology, Diabetes and Metabolism (381 citations), Oncology (531 citations) and Cell Biology (284 citations). E. Galmozzi has collaborated with scholars based in Italy, United States and Australia. Frequent co-authors include Luca Valenti, Silvia Fargion, Paola Dongiovanni, Anna Ludovica Fracanzani, F. Facchetti, Valério Nobili, Raffaela Rametta, Sylvie Ménard, Marco Maggioni and Elisabetta Bugianesi. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, Hepatology, Journal of Viral Hepatitis and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.